CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities
Net loss	$ (7,111,945)	$ (5,221,747)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	55,284	49,269
Bad debt expense	20,068
Amortization of beneficial conversion feature of convertible notes	223,025
Amortization of original issue discounts related to convertible notes	5,791	385,650
Equity compensation expense	1,682,833	1,497,534
Cost of repricing warrants to induce exercise		70,491
Loss on disposal of assets	11,413	9,822
Loss on stock issued for interest	201,175	4,205
Other income from the clawback of equity compensation		(157,920)
Reversal of litigation accrual		(941,000)
Payment by insurance company of prior period litigation expense		(200,000)
Changes in assets and liabilities:
Accounts receivable	(18,067)	17,883
Inventories	(266,574)	(42,585)
Prepaid expenses and other current assets	46,862	26,500
Other assets	(3,200)	(11,255)
Accounts payable	(37,059)	30,748
Accrual for severance agreement	(102,056)	102,056
Deferred revenue	(7,019)	7,019
Accrued expenses	167,450	177,675
Net cash used in operating activities	(5,132,019)	(4,195,655)
Cash flows from Investing Activities
Proceeds from sale of asset		15,000
Purchases of equipment	(72,851)	(43,496)
Net cash used in investing activities	(72,851)	(28,496)
Cash flows from Financing Activities
Proceeds from sale of stock through private placements	2,131,527	1,658,000
Proceeds from the sale of stock and warrants through private placements	1,705,000	300,000
Proceeds from sale of stock under stock purchase agreement	570,000	810,003
Proceeds from exercise of warrants	25,000	910,000
Proceeds from exercise of stock options	18,200	6,534
Repayments of convertible notes from third parties	(115,822)
Payments on notes with related parties	(85,880)	(84,380)
Proceeds from convertible notes with third parties		175,000
Proceeds from convertible notes with related parties	1,000,000	500,000
Payments on insurance finance contract	(67,164)	(44,925)
Net cash provided by financing activities	5,180,861	4,230,232
Net increase (decrease) in cash and cash equivalents	(24,009)	6,081
Cash and cash equivalents - beginning	90,275	84,194
Cash and cash equivalents - ending	66,266	90,275
Supplemental Disclosure of Cash Flow Information:
Cash paid for interest	2,736	2,702
Cash paid for income taxes
Supplementary Disclosure of Non-cash Investing and Financing Activities:
Financing of prepaid insurance contracts	68,942	47,471
Beneficial conversion feature of convertible notes	913,898	309,342
Conversion of notes for common stock	82,132	435,495
Common stock issued for accrued interest	$ 154,251	$ 77,784